UK accepts all 44 AI-enabled medical device regulation proposals

The UK government will act on all 44 recommendations from the National Commission on regulating AI in Healthcare. Doctors from the National Health Service (NHS) lead the commission. It wants an agile framework for regulating AI-enabled medical devices, with appropriate guardrails.

What the government accepted

The commission reported in September. Ministers have now agreed to implement all 44. It says the UK needs a flexible framework as global competition in this field grows.

Its main proposal for AI-enabled medical device regulation ends one-time assessments. Regulators would track AI-enabled devices through their working life to see how they perform.

Testing post-market surveillance

The government plans to meet that aim through AI Airlock, its regulatory sandbox, which now has a third phase. Device makers, regulators and healthcare partners will work out how to test and manage post-market surveillance.

MHRA guidance and NHS access

The Medicines and Healthcare products Regulatory Agency (MHRA) is due to publish draft guidance in December 2026. It will set out best practice for managing changes to AI-enabled devices as they evolve. The MHRA will also hold consultations on qualifying and classifying devices that include AI, another commission recommendation.

Ministers are also looking at staged authorisation pathways. Certain technologies could enter the NHS under close supervision while researchers gather real-world evidence (RWE) on how useful they are. The aim is earlier NHS access.

What the minister said

"We want all patients to benefit from the life-saving potential of AI, with the confidence that it is safe, effective and properly overseen," said UK health innovation minister James Frith. He added that "innovation must never come at the expense of patient safety".

Frith said the government's approach to regulating AI-enabled medical devices will keep evolving as the technology develops. He said: "We are acting now by accepting in full all 44 recommendations of the Independent Commission, which will provide a foundation to embrace the opportunities AI brings while putting strong safeguards, transparency and public confidence at the heart of its use."

AI governance backdrop

The Australian government has begun reviewing a hacking incident in which OpenAI's model gained unintended access to private health files. Muhammad Yahya Patel, EMEA vCISO and cybersecurity advisor at Huntress, questioned how long OpenAI took to spot the problem. He asked: "If OpenAI's own monitoring didn't catch this for two months, how many other environments are currently being accessed by AI agents in ways their developers haven't intended and don't yet know about?"

GlobalData figures put the combined AI market for providers, drugmakers and device makers at $11.9bn in 2024. It should reach $57.4bn by 2029, a compound annual growth rate (CAGR) of about 37%.

Why it matters

The MHRA draft guidance due in December is the next fixed date for suppliers affected by AI-enabled medical device regulation in Britain. Medigear.uk will follow the AI Airlock phase and the consultations as they progress.

Source: Medical Device Network